1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Non-proliferative Diabetic Retinopathy: new trials by email Literature Review of Non-proliferative Diabetic Retinopathy trials Research Report on Non-proliferative Diabetic Retinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants BAY3283142, Placebo - Chronic Kidney Disease, Non-proliferative Diabetic Retinopathy | Phase 1 | Completed | Bayer | 24 | 2024-07-04 | 2024-09-24 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy OTX-TKI, Sham - Non-proliferative Diabetic Retinopathy | Phase 1 | Unknown | Ocular Therapeutix, Inc. | 21 | 2023-01-15 | 2023-12-08 |
Renal Insufficiency, Chronic (1)
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Bayer (1) · Ocular Therapeutix, Inc. (1)
China (1) · United States (1)